Mirati Therapeutics, Inc. today announced that in connection with the hiring, announced on September 20, 2021, of David Meek as Chief Executive Officer, Mr. Meek received an inducement award to purchase up to 150,300 shares of common stock.
September 24, 2021
· 3 min read